Related Experiment Video
Updated: Jun 3, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Phosphate and cardiovascular disease
Jessica Kendrick1, Bryan Kestenbaum, Michel Chonchol
1Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, USA. Jessica.Kendrick@ucdenver.edu
Insights
High phosphate levels, even within normal ranges, increase risks for death and cardiovascular events. Further research is needed to confirm the causal link and guide effective treatments for hyperphosphatemia.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Hyperphosphatemia is a significant risk factor for mortality, cardiovascular events (CVE), and vascular calcification in patients with and without kidney disease.
- Elevated serum phosphate levels, even within the typical laboratory range, are associated with increased risks of death and CVE.
Purpose of the Study:
- To explore the mechanisms linking elevated phosphate to adverse outcomes.
- To highlight the urgent need for clinical trials to establish a causal relationship between phosphate levels and cardiovascular disease.
Main Methods:
- Review of existing epidemiologic data and evidence on potential biological mechanisms.
- Identification of knowledge gaps regarding the direct effects of phosphate on vascular health and hormonal pathways.
Main Results:
- Current evidence suggests direct phosphate effects on vascular calcification.
- Phosphate influences key hormones like fibroblast growth factor-23 and calcitriol.
- Epidemiologic data strongly link phosphate excess to cardiovascular disease.
Conclusions:
- The precise mechanisms of phosphate-induced adverse outcomes require further elucidation.
- Large, randomized clinical trials with hard endpoints are essential to prove or disprove the benefits and risks of phosphate-lowering therapies.
Abstract:
Hyperphosphatemia is a major risk factor for death, CVE, and vascular calcification among patients with and without kidney disease. Even serum phosphate levels within the "normal laboratory range" associate with a greater risk of death and CVE. Potential mechanisms by which increased phosphate results in adverse outcomes are not fully understood, but current evidence suggests a direct effect of phosphate on vascular calcification and modulation of key hormones fibroblast growth factor-23 and calcitriol. Despite convincing epidemiologic connections between phosphate excess and cardiovascular disease, no clinical trials have been conducted to establish a causal relationship, and large, randomized trials with hard endpoints are urgently needed to prove or disprove the benefits and risks of therapy.
Related Concept Videos
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Introduction to Electrolytes
Role of Sodium
One...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Chronic Kidney Disease II: Clinical Manifestations
